{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:630d2ab7-e44e-493b-ae68-da0cffd5c835","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T15:24:35.640655+00:00","published_at":"2026-10-17T04:48:08.708133+00:00","section":"board","data":{"state":"PUBLISHED","size":{"value":1,"assertion_class":"alpha_calculated_metric","basis":"Count of published current board seats in this Record. Roster completeness is not asserted.","input_claim_ids":["alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:9"]},"chair":null,"lead_independent_director":null,"ceo_chair_combined":null,"independence":{"value":{"independent_directors":0,"directors_with_determination":1,"published_directors":1,"independent_share":0},"assertion_class":"alpha_calculated_metric","basis":"Board independence determinations are source facts; the share is computed only over directors with a published determination.","input_claim_ids":["alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:9"]},"average_tenure_years":{"value":{"years":9.8,"directors_with_start_date":1},"assertion_class":"alpha_calculated_metric","basis":"Average tenure at the Record as-of time, bounded by appointment end dates; directors without a published start date are excluded.","input_claim_ids":["alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:9"]},"committee_load":null,"skills_coverage":null,"directors":[{"person":{"alpha_id":"alpha:person:shuling-jiang","name":"Shuling Jiang","canonical_url":"https://registry.alpha.ac/people/shuling-jiang"},"current_role":"Director","director_since":"2017-01-01","director_until":null,"status":"current","independent":{"value":false,"claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2017-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[],"committee_chairs":[],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:che-wei-hsu","name":"Chiao-Ling Hsu","canonical_url":"https://registry.alpha.ac/people/che-wei-hsu"},"current_role":"Director","director_since":null,"director_until":null,"status":"unknown","independent":{"value":true,"claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:5","evidence_ids":["alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":null,"valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[{"person":{"alpha_id":"alpha:person:che-wei-hsu","name":"Chiao-Ling Hsu","canonical_url":"https://registry.alpha.ac/people/che-wei-hsu"},"committee_id":"alpha:committee:abvc-biopharma-inc:audit","committee_name":"Audit","role":"member","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_record:15","evidence_ids":["alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:che-wei-hsu","name":"Chiao-Ling Hsu","canonical_url":"https://registry.alpha.ac/people/che-wei-hsu"},"committee_id":"alpha:committee:abvc-biopharma-inc:audit-compensation-nominating-and-governance","committee_name":"Audit; Compensation; Nominating and Governance","role":"member","valid_from":null,"valid_to":null,"status":"unknown","claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:5","evidence_ids":["alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:che-wei-hsu","name":"Chiao-Ling Hsu","canonical_url":"https://registry.alpha.ac/people/che-wei-hsu"},"committee_id":"alpha:committee:abvc-biopharma-inc:compensation","committee_name":"Compensation","role":"member","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_record:19","evidence_ids":["alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:che-wei-hsu","name":"Chiao-Ling Hsu","canonical_url":"https://registry.alpha.ac/people/che-wei-hsu"},"committee_id":"alpha:committee:abvc-biopharma-inc:nominating-and-governance","committee_name":"Nominating and Governance","role":"member","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_record:23","evidence_ids":["alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b"],"assertion_class":"source_fact","verification_state":"source_reported"}],"committee_chairs":[],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding","director_since"],"claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:5","evidence_ids":["alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:eugene-jiang","name":"Eugene Jiang","canonical_url":"https://registry.alpha.ac/people/eugene-jiang"},"current_role":"Director","director_since":null,"director_until":null,"status":"unknown","independent":{"value":false,"claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":null,"valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[],"committee_chairs":[],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding","director_since"],"claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:hsin-hui-miao","name":"Hsin-Hui Miao","canonical_url":"https://registry.alpha.ac/people/hsin-hui-miao"},"current_role":"Director","director_since":null,"director_until":null,"status":"unknown","independent":{"value":true,"claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":null,"valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[{"person":{"alpha_id":"alpha:person:hsin-hui-miao","name":"Hsin-Hui Miao","canonical_url":"https://registry.alpha.ac/people/hsin-hui-miao"},"committee_id":"alpha:committee:abvc-biopharma-inc:audit","committee_name":"Audit","role":"member","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_record:15","evidence_ids":["alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:hsin-hui-miao","name":"Hsin-Hui Miao","canonical_url":"https://registry.alpha.ac/people/hsin-hui-miao"},"committee_id":"alpha:committee:abvc-biopharma-inc:audit-compensation-nominating-and-governance","committee_name":"Audit; Compensation; Nominating and Governance","role":"member","valid_from":null,"valid_to":null,"status":"unknown","claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:hsin-hui-miao","name":"Hsin-Hui Miao","canonical_url":"https://registry.alpha.ac/people/hsin-hui-miao"},"committee_id":"alpha:committee:abvc-biopharma-inc:compensation","committee_name":"Compensation","role":"member","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_record:19","evidence_ids":["alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:hsin-hui-miao","name":"Hsin-Hui Miao","canonical_url":"https://registry.alpha.ac/people/hsin-hui-miao"},"committee_id":"alpha:committee:abvc-biopharma-inc:nominating-and-governance","committee_name":"Nominating and Governance","role":"member","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_record:23","evidence_ids":["alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b"],"assertion_class":"source_fact","verification_state":"source_reported"}],"committee_chairs":[],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding","director_since"],"claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:norimi-sakamoto","name":"Norimi Sakamoto","canonical_url":"https://registry.alpha.ac/people/norimi-sakamoto"},"current_role":"Director","director_since":null,"director_until":null,"status":"unknown","independent":{"value":true,"claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":null,"valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[{"person":{"alpha_id":"alpha:person:norimi-sakamoto","name":"Norimi Sakamoto","canonical_url":"https://registry.alpha.ac/people/norimi-sakamoto"},"committee_id":"alpha:committee:abvc-biopharma-inc:compensation","committee_name":"Compensation","role":"chair","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_record:19","evidence_ids":["alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:norimi-sakamoto","name":"Norimi Sakamoto","canonical_url":"https://registry.alpha.ac/people/norimi-sakamoto"},"committee_id":"alpha:committee:abvc-biopharma-inc:compensation-chair-nominating-and-governance","committee_name":"Compensation · Chair; Nominating and Governance","role":"member","valid_from":null,"valid_to":null,"status":"unknown","claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:norimi-sakamoto","name":"Norimi Sakamoto","canonical_url":"https://registry.alpha.ac/people/norimi-sakamoto"},"committee_id":"alpha:committee:abvc-biopharma-inc:nominating-and-governance","committee_name":"Nominating and Governance","role":"member","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_record:23","evidence_ids":["alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b"],"assertion_class":"source_fact","verification_state":"source_reported"}],"committee_chairs":["Compensation"],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding","director_since"],"claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:yen-hsin-chou","name":"Yen-Hsin Chou","canonical_url":"https://registry.alpha.ac/people/yen-hsin-chou"},"current_role":"Director","director_since":null,"director_until":null,"status":"unknown","independent":{"value":true,"claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":null,"valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[{"person":{"alpha_id":"alpha:person:yen-hsin-chou","name":"Yen-Hsin Chou","canonical_url":"https://registry.alpha.ac/people/yen-hsin-chou"},"committee_id":"alpha:committee:abvc-biopharma-inc:audit","committee_name":"Audit","role":"chair","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_record:15","evidence_ids":["alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:yen-hsin-chou","name":"Yen-Hsin Chou","canonical_url":"https://registry.alpha.ac/people/yen-hsin-chou"},"committee_id":"alpha:committee:abvc-biopharma-inc:audit-chair","committee_name":"Audit · Chair","role":"member","valid_from":null,"valid_to":null,"status":"unknown","claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b"],"assertion_class":"source_fact","verification_state":"source_reported"}],"committee_chairs":["Audit"],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding","director_since"],"claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:yoshinobu-odaira","name":"Yoshinobu Odaira","canonical_url":"https://registry.alpha.ac/people/yoshinobu-odaira"},"current_role":"Director","director_since":null,"director_until":null,"status":"unknown","independent":{"value":true,"claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":null,"valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[{"person":{"alpha_id":"alpha:person:yoshinobu-odaira","name":"Yoshinobu Odaira","canonical_url":"https://registry.alpha.ac/people/yoshinobu-odaira"},"committee_id":"alpha:committee:abvc-biopharma-inc:nominating-and-governance","committee_name":"Nominating and Governance","role":"chair","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_record:23","evidence_ids":["alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:yoshinobu-odaira","name":"Yoshinobu Odaira","canonical_url":"https://registry.alpha.ac/people/yoshinobu-odaira"},"committee_id":"alpha:committee:abvc-biopharma-inc:nominating-and-governance-chair","committee_name":"Nominating and Governance · Chair","role":"member","valid_from":null,"valid_to":null,"status":"unknown","claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b"],"assertion_class":"source_fact","verification_state":"source_reported"}],"committee_chairs":["Nominating and Governance"],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding","director_since"],"claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:yu-min-francis-chung","name":"Yu-Min (Francis) Chung","canonical_url":"https://registry.alpha.ac/people/yu-min-francis-chung"},"current_role":"Director","director_since":null,"director_until":null,"status":"unknown","independent":{"value":true,"claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":null,"valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[],"committee_chairs":[],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding","director_since"],"claim_id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b"],"assertion_class":"source_fact","verification_state":"source_reported"}],"fields_not_published":["chair","lead_independent_director","board_type","median_tenure","average_age","refreshment_rate","gender_diversity","geographic_diversity","succession_risk","overboarding","board_interlocks","attendance"]},"claims":[{"id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:5","subject_id":"alpha:company:630d2ab7-e44e-493b-ae68-da0cffd5c835","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:che-wei-hsu","object_label":"Chiao-Ling Hsu","object_source_name_forms":[],"value":"Chiao-Ling Hsu: Director, Audit; Compensation; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:che-wei-hsu","name":"Chiao-Ling Hsu"},"title":"Director","role_category":"director","committee":"Audit; Compensation; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:48:08.708133+00:00","sources":[{"id":"alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ABVC BIOPHARMA, INC. DEF 14A 2026-03-05","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1173313/000121390026024122/ea0279808-def14a_abvc.htm","source_date":"2026-03-05","retrieved_at":"2026-04-24T20:03:02.242+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-05","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:48:08.708133+00:00","reviewed_at":"2026-10-17T04:48:08.708133+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:6","subject_id":"alpha:company:630d2ab7-e44e-493b-ae68-da0cffd5c835","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:eugene-jiang","object_label":"Eugene Jiang","object_source_name_forms":[],"value":"Eugene Jiang: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:eugene-jiang","name":"Eugene Jiang"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:48:08.708133+00:00","sources":[{"id":"alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ABVC BIOPHARMA, INC. DEF 14A 2026-03-05","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1173313/000121390026024122/ea0279808-def14a_abvc.htm","source_date":"2026-03-05","retrieved_at":"2026-04-24T20:03:02.242+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-05","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:48:08.708133+00:00","reviewed_at":"2026-10-17T04:48:08.708133+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:7","subject_id":"alpha:company:630d2ab7-e44e-493b-ae68-da0cffd5c835","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:hsin-hui-miao","object_label":"Hsin-Hui Miao","object_source_name_forms":[],"value":"Hsin-Hui Miao: Director, Audit; Compensation; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:hsin-hui-miao","name":"Hsin-Hui Miao"},"title":"Director","role_category":"director","committee":"Audit; Compensation; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:48:08.708133+00:00","sources":[{"id":"alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ABVC BIOPHARMA, INC. DEF 14A 2026-03-05","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1173313/000121390026024122/ea0279808-def14a_abvc.htm","source_date":"2026-03-05","retrieved_at":"2026-04-24T20:03:02.242+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-05","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:48:08.708133+00:00","reviewed_at":"2026-10-17T04:48:08.708133+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:8","subject_id":"alpha:company:630d2ab7-e44e-493b-ae68-da0cffd5c835","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:norimi-sakamoto","object_label":"Norimi Sakamoto","object_source_name_forms":[],"value":"Norimi Sakamoto: Director, Compensation · Chair; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:norimi-sakamoto","name":"Norimi Sakamoto"},"title":"Director","role_category":"director","committee":"Compensation · Chair; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:48:08.708133+00:00","sources":[{"id":"alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ABVC BIOPHARMA, INC. DEF 14A 2026-03-05","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1173313/000121390026024122/ea0279808-def14a_abvc.htm","source_date":"2026-03-05","retrieved_at":"2026-04-24T20:03:02.242+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-05","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:48:08.708133+00:00","reviewed_at":"2026-10-17T04:48:08.708133+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:9","subject_id":"alpha:company:630d2ab7-e44e-493b-ae68-da0cffd5c835","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:shuling-jiang","object_label":"Shuling Jiang","object_source_name_forms":[],"value":"Shuling Jiang: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:shuling-jiang","name":"Shuling Jiang"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-17T04:48:08.708133+00:00","sources":[{"id":"alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ABVC BIOPHARMA, INC. DEF 14A 2026-03-05","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1173313/000121390026024122/ea0279808-def14a_abvc.htm","source_date":"2026-03-05","retrieved_at":"2026-04-24T20:03:02.242+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-05","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-17T04:48:08.708133+00:00","reviewed_at":"2026-10-17T04:48:08.708133+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:10","subject_id":"alpha:company:630d2ab7-e44e-493b-ae68-da0cffd5c835","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:yen-hsin-chou","object_label":"Yen-Hsin Chou","object_source_name_forms":[],"value":"Yen-Hsin Chou: Director, Audit · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:yen-hsin-chou","name":"Yen-Hsin Chou"},"title":"Director","role_category":"director","committee":"Audit · Chair","is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:48:08.708133+00:00","sources":[{"id":"alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ABVC BIOPHARMA, INC. DEF 14A 2026-03-05","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1173313/000121390026024122/ea0279808-def14a_abvc.htm","source_date":"2026-03-05","retrieved_at":"2026-04-24T20:03:02.242+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-05","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:48:08.708133+00:00","reviewed_at":"2026-10-17T04:48:08.708133+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:11","subject_id":"alpha:company:630d2ab7-e44e-493b-ae68-da0cffd5c835","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:yoshinobu-odaira","object_label":"Yoshinobu Odaira","object_source_name_forms":[],"value":"Yoshinobu Odaira: Director, Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:yoshinobu-odaira","name":"Yoshinobu Odaira"},"title":"Director","role_category":"director","committee":"Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:48:08.708133+00:00","sources":[{"id":"alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ABVC BIOPHARMA, INC. DEF 14A 2026-03-05","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1173313/000121390026024122/ea0279808-def14a_abvc.htm","source_date":"2026-03-05","retrieved_at":"2026-04-24T20:03:02.242+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-05","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:48:08.708133+00:00","reviewed_at":"2026-10-17T04:48:08.708133+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:leadership_role:12","subject_id":"alpha:company:630d2ab7-e44e-493b-ae68-da0cffd5c835","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:yu-min-francis-chung","object_label":"Yu-Min (Francis) Chung","object_source_name_forms":[],"value":"Yu-Min (Francis) Chung: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:yu-min-francis-chung","name":"Yu-Min (Francis) Chung"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:48:08.708133+00:00","sources":[{"id":"alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ABVC BIOPHARMA, INC. DEF 14A 2026-03-05","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1173313/000121390026024122/ea0279808-def14a_abvc.htm","source_date":"2026-03-05","retrieved_at":"2026-04-24T20:03:02.242+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-05","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:48:08.708133+00:00","reviewed_at":"2026-10-17T04:48:08.708133+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_record:15","subject_id":"alpha:company:630d2ab7-e44e-493b-ae68-da0cffd5c835","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Yen-Hsin Chou; Members Yen-Hsin Chou (Chair); Chiao-Ling Hsu; Hsin-Hui Miao","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Yen-Hsin Chou","members":[{"display_name":"Yen-Hsin Chou","person_slug":"yen-hsin-chou","is_chair":true},{"display_name":"Chiao-Ling Hsu","person_slug":"che-wei-hsu","is_chair":false},{"display_name":"Hsin-Hui Miao","person_slug":"hsin-hui-miao","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:48:08.708133+00:00","sources":[{"id":"alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1173313/000121390026024122/ea0279808-def14a_abvc.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:48:08.708133+00:00","reviewed_at":"2026-10-17T04:48:08.708133+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_record:19","subject_id":"alpha:company:630d2ab7-e44e-493b-ae68-da0cffd5c835","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair Norimi Sakamoto; Members Norimi Sakamoto (Chair); Chiao-Ling Hsu; Hsin-Hui Miao","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"Norimi Sakamoto","members":[{"display_name":"Norimi Sakamoto","person_slug":"norimi-sakamoto","is_chair":true},{"display_name":"Chiao-Ling Hsu","person_slug":"che-wei-hsu","is_chair":false},{"display_name":"Hsin-Hui Miao","person_slug":"hsin-hui-miao","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:48:08.708133+00:00","sources":[{"id":"alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1173313/000121390026024122/ea0279808-def14a_abvc.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:48:08.708133+00:00","reviewed_at":"2026-10-17T04:48:08.708133+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:630d2ab7-e44e-493b-ae68-da0cffd5c835:committee_record:23","subject_id":"alpha:company:630d2ab7-e44e-493b-ae68-da0cffd5c835","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair Yoshinobu Odaira; Members Yoshinobu Odaira (Chair); Chiao-Ling Hsu; Hsin-Hui Miao; Norimi Sakamoto","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":"Yoshinobu Odaira","members":[{"display_name":"Yoshinobu Odaira","person_slug":"yoshinobu-odaira","is_chair":true},{"display_name":"Chiao-Ling Hsu","person_slug":"che-wei-hsu","is_chair":false},{"display_name":"Hsin-Hui Miao","person_slug":"hsin-hui-miao","is_chair":false},{"display_name":"Norimi Sakamoto","person_slug":"norimi-sakamoto","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:48:08.708133+00:00","sources":[{"id":"alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1173313/000121390026024122/ea0279808-def14a_abvc.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:48:08.708133+00:00","reviewed_at":"2026-10-17T04:48:08.708133+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:29345cf37ff738fda30fe64218c1c268e8578bc447ff3be8fb0a4728e3c0479b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ABVC BIOPHARMA, INC. DEF 14A 2026-03-05","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1173313/000121390026024122/ea0279808-def14a_abvc.htm","source_date":"2026-03-05","retrieved_at":"2026-04-24T20:03:02.242+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:d0605426ad593d3c9741529f14c5e08dccb8d608cfc8a721f5602e45c9e7d55b","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1173313/000121390026024122/ea0279808-def14a_abvc.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.818,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.904,"cross_source_agreement":0.75,"temporal_completeness":0.15},"diagnostics":{"published_claims":27,"factual_claims":27,"claims_with_linked_evidence":27,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":20,"temporal_claims_with_valid_from":3,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:48:08.708133+00:00","observed_at":"2026-10-17T04:48:08.708133+00:00","reviewed_at":"2026-10-17T04:48:08.708133+00:00","verified_at":"2026-10-17T04:48:08.708133+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":27,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/abvc-biopharma-inc/board","section":"board","href":"https://registry.alpha.ac/api/public/companies/abvc-biopharma-inc?format=record&section=board","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}